Patents Assigned to Sterling Drug Inc.
  • Patent number: 5122541
    Abstract: A sprayable aqueous disinfecting composition for disinfecting hard surfaces comprising 20 to 30% by weight of a mixture of ethyl alcohol and isopropyl alcohol in a weight ratio of 1:2 to 2:1, 0.05 to 0.5% by weight of a mixture of a primary or secondary C.sub.10-18 -alkane sulfonate and/or a C.sub.10-18 -alkyl sulfate with a C.sub.10-14 -alkyl ether sulfate, a pH adjusting agent for adjusting the pH in the range of 2 to 6 or 8 to 12, and the remainder to 100% by weight water.
    Type: Grant
    Filed: February 20, 1990
    Date of Patent: June 16, 1992
    Assignee: Sterling Drug, Inc.
    Inventors: Heinz Eggensperger, Ute Eggers-Maass, Bernd Lower, Holger Brill, Helmut Nolte
  • Patent number: 5115951
    Abstract: An L-shaped dispensing wand has one end fitted into an insert previously snap fitted into the neck of a container, such as a rectangular metal can. The wand has an array of holes along the top side thereof which face downward when the can is inverted to sprinkle the area beneath the can. Preferably, the L-shaped dispensing wand is made of two portions which are packaged side-by-side and retained on top of the can prior to sale of the can. The customer assembles the sections to form the L-shaped wand and inserts the wand into the insert within the can. The insert includes a plurality of vent holes therein, which allow air to enter the can and reduce the vacuum tending to occur in the can as the can drains.
    Type: Grant
    Filed: January 23, 1991
    Date of Patent: May 26, 1992
    Assignee: Sterling Drug, Inc.
    Inventors: Stuart Leslie, Thomas B. Aldrich, III
  • Patent number: 5112820
    Abstract: Antiglaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-[1,2,3-de]-1,4-benzoxazines as the active component thereof and the method of use thereof in the treatment of glaucoma.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: May 12, 1992
    Assignee: Sterling Drug Inc.
    Inventor: Susan J. Ward
  • Patent number: 5110821
    Abstract: Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms;R' is lower-alkyl or hydroxy-lower-alkyl or 1-5 carbon atoms;R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; andR.sub.8 is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when R.sub.8 is hydrogen R' is hydroxy-lower-alkyl,are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.
    Type: Grant
    Filed: June 7, 1990
    Date of Patent: May 5, 1992
    Assignee: Sterling Drug Inc.
    Inventor: Guy D. Diana
  • Patent number: 5109135
    Abstract: 2- and 3-Aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo[1,2,3-de]-1,4-benzoxazines , useful as analgesic agents, are prepared either by reaction of a 2- or 3-aminomethyl-2,3-dihydropyrrolo[1,2,3-de]-1,4-benzoxazine with an arylcarboxylic acid halide in the presence of a Lewis acid or by reaction of a 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine with a 1-lower-alkyl-3-aryl-1,3-diketone or with a .beta.-aryl-.beta.-ketopropionaldehyde under dehydrating conditions and heating the resulting hydrazone in an acid medium.
    Type: Grant
    Filed: August 13, 1991
    Date of Patent: April 28, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Thomas E. D'Ambra, Malcolm R. Bell
  • Patent number: 5106844
    Abstract: Novel imidazo[2,1-b][3]benzazepines and pyrimido[2,1-b][3]benzazepines of formula I, pharmaceutical compositions containing them, methods for treating cardiac arrhythmia in mammals utilizing them, and processes for synthesizing them.
    Type: Grant
    Filed: September 10, 1991
    Date of Patent: April 21, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Robert E. Johnson, Carl A. Busacca
  • Patent number: 5100918
    Abstract: Ultraviolet radiation induced erythema is prevented or treated in a human mammal in need of such prevention or treatment, i.e., a mammal suffering from or seeking to avoid sunburn, by topically administering thereto a unit dosage erythema-preventing or treating effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
    Type: Grant
    Filed: October 5, 1990
    Date of Patent: March 31, 1992
    Assignee: Sterling Drug, Inc.
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 5100882
    Abstract: 5'-Alkylsulfonylsteroido[3,2-b]furans, for example 5'-methylsulfonyl-5.alpha.-pregn-2-en-20-yno[3,2-b]furan-17.beta.-ol having the structural formula, ##STR1## which are useful as antiandrogenic agents, and processes for preparation, method of use and compositions thereof are disclosed.
    Type: Grant
    Filed: June 21, 1990
    Date of Patent: March 31, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Robert G. Christiansen, Malcolm R. Bell, Virendra Kumar
  • Patent number: 5098901
    Abstract: Novel imidazo[1,2-b][2]benzazepines and pyrimido[1,2-b][2]benzazepines of formula I, pharmaceutical compositions containing them, methods for treating cardiac arrhythmias in mammals utilizing them, and processes for synthesizing them.
    Type: Grant
    Filed: September 10, 1991
    Date of Patent: March 24, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Robert E. Johnson, Carl A. Busacca
  • Patent number: 5080886
    Abstract: The combination of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid with a superoxide dismutase optionally containing a catalase and ascorbic acid provides enhanced protection from oxidant injury.Administration of 6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, SOD, and optionally CAT and/or ascorbic acid prior to or simultaneously with resuming normal blood supply to mammalian tissue following ischemia provides substantial protection from tissue damage that otherwise is observed upon reperfusion. Administration of Vitamin E, SOD, and CAT similarly provide protection from oxidant injury.
    Type: Grant
    Filed: January 5, 1990
    Date of Patent: January 14, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Donald A. G. Mickle, Tai-Wing Wu
  • Patent number: 5081122
    Abstract: Antiglaucoma compositions containing 3-R.sub.3 -4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles and a method of use thereof in the treatment of glaucoma.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: January 14, 1992
    Assignee: Sterling Drug Inc.
    Inventor: Susan J. Ward
  • Patent number: 5078698
    Abstract: A hypodermic syringe holder adapted to receive a disposable carpule and eject it in an axial direction includes a pair of pivotable jaws disposed on pivots on opposite sides of the body of the holder and a sleeve element for opening and closing the jaws slidably disposed around the body of the holder. In the downward position, the sleeve element closes the jaws around the carpule and in the upward position, the sleeve opens the jaws, permitting the carpule to be safely and consistently ejected form the holder in an axial direction.
    Type: Grant
    Filed: February 19, 1991
    Date of Patent: January 7, 1992
    Assignee: Sterling Drug Inc.
    Inventors: Mark A. Stiehl, Eugene Sisto
  • Patent number: 5075319
    Abstract: Fluorinated 1-cyclopropyl-7-(substituted-pyridinyl)-1,4-dihydro-4-oxo-3-quinolinecarbo xylic acids of the formula ##STR1## wherein R is hydrogen, R' and R" are hydrogen or fluoro, or other groups and Z is 3- or 4-pyridinyl substituted by alkyl groups or substituted alkyl groups, are superior antibacterial agents. They are prepared via a coupling reaction between the corresponding esters (R=alkyl) having a halo group in the 7-position and a substituted (trialkylstannyl)pyridine.
    Type: Grant
    Filed: September 13, 1989
    Date of Patent: December 24, 1991
    Assignee: Sterling Drug Inc.
    Inventors: George Y. Lesher, Baldev Singh, Michael Reuman
  • Patent number: 5068234
    Abstract: 2-R.sub.2 -R.sub.4 -substituted-3-R.sub.3 -CO-1-[(C-attached-N-herteryl)-(Alk).sub.n ]-1H-indoles useful as analgesic, anti-rheumatic, anti-inflammatory or anti-glaucoma agents.
    Type: Grant
    Filed: February 26, 1990
    Date of Patent: November 26, 1991
    Assignee: Sterling Drug Inc.
    Inventors: Thomas E. D'Ambra, Edward R. Bacon, Malcolm R. Bell, Philip M. Carabateas, Michael A. Eissenstat, Virendra Kumar, John P. Mallamo, Susan J. Ward
  • Patent number: 5066803
    Abstract: 2- and 3-Aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo[1,2,3-de]-1,4-benzoxazines , useful as analgesic agents, are prepared either by reaction of a 2- or 3-aminomethyl-2,3-dihydropyrrolo[1,2,3-de]-1,4-benzoxazine with an arylcarboxylic acid halide in the presence of a Lewis acid or by reaction of 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine with a 1-lower-alkyl-3-aryl-1,3-diketone or with a .beta.-aryl-.beta.-ketopropionaldehyde under dehydrating conditions and heating the resulting hydrazone in an acid medium.
    Type: Grant
    Filed: April 16, 1990
    Date of Patent: November 19, 1991
    Assignee: Sterling Drug Inc.
    Inventors: Thomas E. D'Ambra, Malcolm R. Bell
  • Patent number: 5053405
    Abstract: 2'-Alkylsulfonylsteroido[3,2-d]thiazoles, for example 2'-methylsulfonyl-5.alpha.-pregn-2-en-20-yno[3,2-d]thiazol-17.beta.-ol, which are useful as antiandrogenic agents, and processes for preparation, method of use and compositions thereof are disclosed.
    Type: Grant
    Filed: June 21, 1990
    Date of Patent: October 1, 1991
    Assignee: Sterling Drug Inc.
    Inventors: Garry M. Pilling, John P. Mallamo
  • Patent number: 5051437
    Abstract: Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms;Z is N or HC;R is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when Z is N, R is lower-alkyl;R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; andHet is selected from thiazole, benzothiazole and benzoxazole groups,are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.
    Type: Grant
    Filed: August 18, 1989
    Date of Patent: September 24, 1991
    Assignee: Sterling Drug Inc.
    Inventor: Guy D. Diana
  • Patent number: 5047258
    Abstract: A process for spray-coating tablets and the like utilizing only an acrylate enteric polymer and plasticizer in water is disclosed. The process can be practiced on a commercial scale and requires no antiadherent in the coating formulation. The process comprises providing inlet air having a dew point below about 10.degree. C. and a temperature between 35.degree. and 60.degree. C.
    Type: Grant
    Filed: December 4, 1990
    Date of Patent: September 10, 1991
    Assignee: Sterling Drug Inc.
    Inventors: Raymond J. Belanger, Gregg Stetsko, Shrikant N. Pagay
  • Patent number: 5034219
    Abstract: A hair conditioning composition which when applied to color-treated hair prior to perming with formulations based on thioglycolate or sulfite minimizes the reduction in tensile strength of the hair comprising about 0.1 to about 4.0 weight-percent of a water-dispersible dialkyl (C.sub.12-18) dimethyl ammonium halide; about 0.1 to about 2.5 weight-percent of alkyl (C.sub.12-18) dimethyl benzyl ammonium halide; about 0.1 to about 2.0 weight-percent of a homopolymer of diallyl dialkyl ammonium halide; optionally a thickener, a moisturizer, an emulsifier, a protein conditioner, a preservative, a colorant, and/or a perfume; and the remainder to 100 weight-percent water; and a method of conditioning color-treated hair therewith.
    Type: Grant
    Filed: March 13, 1989
    Date of Patent: July 23, 1991
    Assignee: Sterling Drug Inc.
    Inventors: Vikas M. Deshpande, John M. Walts
  • Patent number: 5017584
    Abstract: 2-(4,5-Dihydro-1H-imidazol-2-yl)-2,3-dihydro-1H-indoles, 2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,3,4-tetrahydroquinolines and 2-(4,5-dihydro-1H-imidazol-2-yl)-1H-indoles, useful as antidepressant agents, are prepared by reacting a respective lower-alkyl 2,3-dihydro-1H-indole-2-carboxylate 1,2,3,4-tetrahydroquinoline-2-carboxylate or 1H-indole-2-carboxylate derivative with ethylenediamine or an N-lower-alkylethylenediamine in the presence of a Lewis-type acid.
    Type: Grant
    Filed: November 27, 1985
    Date of Patent: May 21, 1991
    Assignee: Sterling Drug Inc.
    Inventor: Dennis J. Hlasta